Ginkgo Bioworks Holdings (DNA) Assets (2020 - 2026)

Ginkgo Bioworks Holdings has reported Assets for 7 years, with the latest figure at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 20.13% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (down 20.13% YoY), and the FY2025 full-year result was $1.1 billion, down 18.71% from the prior year.
• Assets for Q1 2026 stood at $1.0 billion, down from $1.1 billion in the prior quarter.
• The five-year high for Assets was $2.5 billion in Q4 2022, with the low at $1.0 billion in Q1 2026.
• Historically, Assets has averaged $1.7 billion across 5 years, with a median of $1.6 billion in 2024.
• Annual changes were most pronounced in 2022 — Assets rose 22.61% — and 2024, when it tumbled 34.56%.
• Ginkgo Bioworks Holdings' Assets stood at $2.5 billion in 2022, then sank by 34.42% to $1.7 billion in 2023, then declined by 17.29% to $1.4 billion in 2024, then decreased by 18.71% to $1.1 billion in 2025, then fell by 7.74% to $1.0 billion in 2026.
• The last three Assets figures came in at $1.0 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.